169 related articles for article (PubMed ID: 26450638)
1. Combined systemic and ocular chemotherapy for anterior segment metastasis of systemic mantle cell lymphoma.
Agarwal A; Sadiq MA; Rhoades WR; Jack LS; Hanout M; Bierman PJ; West WW; Nguyen QD
J Ophthalmic Inflamm Infect; 2015 Dec; 5(1):30. PubMed ID: 26450638
[TBL] [Abstract][Full Text] [Related]
2. Bilateral mantle cell lymphoma of the ciliary body that responded to a combined local radiotherapy and chemotherapy regimen: a case report.
Pei M; Zhao C; Gao F; Zhang M
BMC Cancer; 2019 Apr; 19(1):355. PubMed ID: 30987612
[TBL] [Abstract][Full Text] [Related]
3. Successful Use of Intravitreal Bevacizumab and Methotrexate in a Case of Neovascularization of the Iris and Pseudohypopyon Secondary to Recurrent Diffuse Large B-Cell Lymphoma.
Ahmed H; James A; Enghelberg M
Cureus; 2022 Feb; 14(2):e22578. PubMed ID: 35371675
[TBL] [Abstract][Full Text] [Related]
4. Blastic Transformation of a Mantle Cell Lymphoma Presenting as an Enlarging Unilateral Orbital Mass.
De Niear MA; Greer JP; Seegmiller A; Mawn LA
Ocul Oncol Pathol; 2019 Jun; 5(4):245-251. PubMed ID: 31367585
[TBL] [Abstract][Full Text] [Related]
5. Immunotherapy in mantle cell lymphoma: anti-CD20-based therapy and beyond.
Zhou Y; Zhang L; Romaguera J; Delasalle K; Han X; Du X; Kwak L; Yi Q; Wang M
Am J Hematol; 2008 Feb; 83(2):144-9. PubMed ID: 17722077
[TBL] [Abstract][Full Text] [Related]
6. Diffuse large B-cell lymphoma and mantle cell lymphoma of the ocular adnexal region, and lymphoma of the lacrimal gland: an investigation of clinical and histopathological features.
Rasmussen PK
Acta Ophthalmol; 2013 Jul; 91 Thesis 5():1-27. PubMed ID: 24041159
[TBL] [Abstract][Full Text] [Related]
7. Intraocular mantle cell lymphoma of the iris.
Reid JP; Puglis CL; Slagle WS
Optom Vis Sci; 2014 Apr; 91(4 Suppl 1):S25-9. PubMed ID: 24637484
[TBL] [Abstract][Full Text] [Related]
8. Intraocular lymphoma masquerading as unilateral hypopyon anterior uveitis: a case report.
Zamani G; Hajipour A; Ganjeifar B; Ebrahimiadib N; Hosseini SM
J Ophthalmic Inflamm Infect; 2022 Jul; 12(1):25. PubMed ID: 35900606
[TBL] [Abstract][Full Text] [Related]
9. Blastic variant of mantle cell lymphoma: a rare but highly aggressive subtype.
Bernard M; Gressin R; Lefrère F; Drénou B; Branger B; Caulet-Maugendre S; Tass P; Brousse N; Valensi F; Milpied N; Voilat L; Sadoun A; Ghandour C; Hunault M; Leloup R; Mannone L; Hermine O; Lamy T
Leukemia; 2001 Nov; 15(11):1785-91. PubMed ID: 11681422
[TBL] [Abstract][Full Text] [Related]
10. Mantle Cell Lymphoma Relapsing as Disease of Skin, Orbit and CNS: An Extremely Rare Presentation and a Review of Literature.
Shaikh H; Jani P; Shah R; Bilimoria F; Uchin J; Mewawalla P
J Hematol; 2018 Jan; 7(1):38-42. PubMed ID: 32300410
[TBL] [Abstract][Full Text] [Related]
11. Cutaneous involvement as a rare first sign of systemic mantle cell lymphoma: A case report and review of the literature.
Hrgovic I; Hartmann S; Steffen B; Vogl T; Kaufmann R; Meissner M
Mol Clin Oncol; 2016 May; 4(5):728-732. PubMed ID: 27123271
[TBL] [Abstract][Full Text] [Related]
12. Hypopyon uveitis and iris nodules in non-Hodgkin's lymphoma: ocular relapse during systemic remission.
Verity DH; Graham EM; Carr R; van der Walt JD; Stanford MR
Clin Oncol (R Coll Radiol); 2000; 12(5):292-4. PubMed ID: 11315712
[TBL] [Abstract][Full Text] [Related]
13. Mantle cell lymphoma: 2012 update on diagnosis, risk-stratification, and clinical management.
Vose JM
Am J Hematol; 2012 Jun; 87(6):604-9. PubMed ID: 22615102
[TBL] [Abstract][Full Text] [Related]
14. Diffuse aggressive lymphoma.
Fisher RI; Miller TP; O'Connor OA
Hematology Am Soc Hematol Educ Program; 2004; ():221-36. PubMed ID: 15561685
[TBL] [Abstract][Full Text] [Related]
15. Mantle cell lymphoma in the orbital and adnexal region.
Rasmussen P; Sjö LD; Prause JU; Ralfkiaer E; Heegaard S
Br J Ophthalmol; 2009 Aug; 93(8):1047-51. PubMed ID: 19429588
[TBL] [Abstract][Full Text] [Related]
16. IDEC-C2B8 anti-CD20 (rituximab) immunotherapy in patients with low-grade non-Hodgkin's lymphoma and lymphoproliferative disorders: evaluation of response on 48 patients.
Nguyen DT; Amess JA; Doughty H; Hendry L; Diamond LW
Eur J Haematol; 1999 Feb; 62(2):76-82. PubMed ID: 10052709
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathological Features of Ocular Adnexal Mantle-Cell Lymphoma in an International Multicenter Cohort.
Knudsen MKH; Rasmussen PK; Coupland SE; Esmaeli B; Finger PT; Graue GF; Grossniklaus HE; Khong JJ; McKelvie PA; Mulay K; Ralfkiaer E; Sjö LD; Vemuganti GK; Thuro BA; Curtin J; Heegaard S
JAMA Ophthalmol; 2017 Dec; 135(12):1367-1374. PubMed ID: 29121219
[TBL] [Abstract][Full Text] [Related]
18. Ofatumumab Exhibits Enhanced In Vitro and In Vivo Activity Compared to Rituximab in Preclinical Models of Mantle Cell Lymphoma.
Barth MJ; Mavis C; Czuczman MS; Hernandez-Ilizaliturri FJ
Clin Cancer Res; 2015 Oct; 21(19):4391-7. PubMed ID: 25964296
[TBL] [Abstract][Full Text] [Related]
19. [A patient with mantle cell lymphoma who successfully underwent auto-PBSCT in combination with in vivo purging of tumor cells using rituximab].
Kanaji N; Ishibashi K; Uno H; Hino N
Gan To Kagaku Ryoho; 2002 Dec; 29(13):2569-72. PubMed ID: 12506485
[TBL] [Abstract][Full Text] [Related]
20. Blastic Mantle Cell Lymphoma of the Gastroesophageal Junction: A Unique Presentation and Literature Review.
Ahmed AM; Vossough S
Case Rep Gastroenterol; 2021; 15(1):70-79. PubMed ID: 33613166
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
